about
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pa...
Read More916.3K XNAS Volume
XNAS 13 May, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Alector Inc is on 15 May 2025 for the purpose of Alector Inc First Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Alector Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..